Dillione Janet

Track

Insider profile

Performance

Overall performance
3.1
Performance over holding periods
4.2
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 53% 68% 82%
Transactions
7 29% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 54%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Dillione Janet's trades of CorMedix Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
400.92
Quantity 11,755 +17.1%
Value US$4,862,141
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
25.33
Quantity 17,561
Value US$3,286,687
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
173.61
Quantity 23,415 -13.0%
Value US$4,942,004
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
12.00
Quantity 34,000
Value US$408,000
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
10.00
Quantity 46,657 -49.0%
Value US$466,570
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
9.93
Quantity 26,343 -35.2%
Value US$261,586
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
9.97
Quantity 73,000
Value US$727,927
US CorMedix Inc (CRMD)
Transaction date
Sale
Price
11.42
Quantity 30,000 -38.2%
Value US$342,600
US CorMedix Inc (CRMD)
Transaction date
Proposed sale
Price
10.94
Quantity 30,000
Value US$328,200
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
6.74
Quantity 11,144 +30.8%
Value US$75,111
US CorMedix Inc (CRMD)
Transaction date
Purchase
Price
1.67
Quantity 42,000 +30.2%
Value US$69,972
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-22 2026-01-21
US CorMedix Inc (CRMD)
S Sale
11,755 +17.1%
400.92
US$4,862,141 		11,755 +17.1% 400.92 US$4,862,141
2026-01-21 2026-01-21
US CorMedix Inc (CRMD)
PrS Proposed sale
17,561
25.33
US$3,286,687 		17,561 25.33 US$3,286,687
2025-12-11 2025-12-09
US CorMedix Inc (CRMD)
S Sale
23,415 -13.0%
173.61
US$4,942,004 		23,415 -13.0% 173.61 US$4,942,004
2025-12-09 2025-12-09
US CorMedix Inc (CRMD)
PrS Proposed sale
34,000
12.00
US$408,000 		34,000 12.00 US$408,000
2025-12-04 2025-12-02
US CorMedix Inc (CRMD)
S Sale
46,657 -49.0%
10.00
US$466,570 		46,657 -49.0% 10.00 US$466,570
2025-11-26 2025-11-24
US CorMedix Inc (CRMD)
S Sale
26,343 -35.2%
9.93
US$261,586 		26,343 -35.2% 9.93 US$261,586
2025-11-24 2025-11-24
US CorMedix Inc (CRMD)
PrS Proposed sale
73,000
9.97
US$727,927 		73,000 9.97 US$727,927
2025-11-18 2025-11-14
US CorMedix Inc (CRMD)
S Sale
30,000 -38.2%
11.42
US$342,600 		30,000 -38.2% 11.42 US$342,600
2025-11-14 2025-11-14
US CorMedix Inc (CRMD)
PrS Proposed sale
30,000
10.94
US$328,200 		30,000 10.94 US$328,200
2019-05-17 2019-05-15
US CorMedix Inc (CRMD)
B Purchase
11,144 +30.8%
6.74
US$75,111 		11,144 +30.8% 6.74 US$75,111
2019-03-20 2019-03-18
US CorMedix Inc (CRMD)
B Purchase
42,000 +30.2%
1.67
US$69,972 		42,000 +30.2% 1.67 US$69,972